Moreover, the isogenic knockdown of p53 in our MCF-7 cell line model is characteristic of breast cancers with p53 mutation/inactivation, which represents up to 70–80% of human breast cancers [29, 30]. This evidence concerns the gene TP53 and breast carcinoma.